Bausch Health Companies Inc.

NYSE:BHC

Drug Manufacturers - Specialty & Generic

Healthcare
$8.73 -2.21%

-$0.11 today

Market cap
$3.27B
Beta
0.41
P/E (TTM)
-1.5
EPS (TTM)
-$3.19
52W Low $4.57High $8.69

Volume 6.83M

Average 1.70M

BHC Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Bausch Health Companies Inc.NYSE: BHC

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 72.9%

Gross margin was 72.9% in Q2 FY2026, up 3.1 pp from a year earlier. On a trailing-twelve-month basis it was 71.8%, up 1.1 pp year over year. Over 3 fiscal years it narrowed by 0.3 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
72.9%+2.2 pp QoQ
Last fiscal yearDec 2025
70.7%-0.4 pp YoY
LTMJun 2026
71.8%+1.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.1 pp——
1 year-0.4 pp——
3 years-0.3 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
70.7%
Year-over-year change
-0.4pp

Gross Margin vs competitors

How BHC compares with its peers on the latest reported figures

  • BHC's LTM Jun 2026 gross margin of 71.8% is the 3rd highest of the 10 companies compared; the peer median is 57.4%.
  • Its year-over-year change of +1.1 pp is the 3rd highest of 10, against a peer median of +0.0 pp.
  • Over three fiscal years its change of -0.3 pp compares with a peer median of +2.4 pp.
BHC Competitors Peer median
Gross Margin for BHC and competitors
Company Period LTM level YoY 3-year change
BEAMBeam Therapeutics Inc.LTM Jun 2026100.0% +0.0 pp+495.5 pp
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 202682.3% -3.8 pp+1.2 pp
BHCBausch Health Companies Inc.LTM Jun 202671.8% +1.1 pp-0.3 pp
ANIPANI Pharmaceuticals, Inc.LTM Mar 202665.9% +6.6 pp-5.1 pp
ALVOAlvotechLTM Mar 202661.4% +0.8 pp+37.0 pp
HAEHaemonetics CorporationLTM Jun 202657.4% +0.6 pp+2.4 pp
XRAYDENTSPLY SIRONA Inc.LTM Mar 202648.9% -2.6 pp-4.2 pp
PRGOPerrigo Company plcLTM Jun 202633.3% -2.5 pp+2.4 pp
CONConcentra Group Holdings Parent, Inc.LTM Sep 202629.9% +1.5 pp+4.7 pp
HCMHUTCHMED (China) LimitedLTM Jun 20258.9% -20.9 pp+11.6 pp
MLYSMineralys Therapeutics, Inc.FY2025— ——
Peer median (excluding BHC) 57.4%+0.0 pp+2.4 pp

Competitors are the stored peer set for BHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue8.43B8.12B8.76B9.63B10.27B
Cost of Revenue2.39B2.36B2.56B2.78B3.01B
Gross Profit6.04B5.76B6.2B6.84B7.25B
Gross Margin71.6%70.9%70.8%71.1%70.7%
Research & Development473M530M604M634M629M
Selling, General & Admin2.49B2.53B2.9B3.28B3.44B
Operating Expenses5.59B5.31B5.24B5.3B5.07B
Depreciation & Amortization1.55B1.39B1.26B1.27B1.21B
EBITDA3.26B2.88B2.89B3.13B3.18B
EBITDA Margin38.7%35.4%32.9%32.6%31.0%
Operating Income450M454M963M1.55B2.19B
Operating Margin5.3%5.6%11.0%16.1%21.3%
Interest Income7M14M26M33M48M
Interest Expense1.43B1.46B1.33B1.39B1.6B
Other Income / Expenses(1.47B)(583M)(1.35B)(1.38B)(1.82B)
Income Before Tax(1.02B)(129M)(390M)167M367M
Pre-Tax Margin-12.1%-1.6%-4.5%1.7%3.6%
Income Tax Expense(87M)83M221M239M247M
Net Income(948M)(225M)(592M)(46M)157M
Net Margin-11.2%-2.8%-6.8%-0.5%1.5%
EPS (Basic)(2.61)(0.62)(1.62)(0.13)0.43
EPS (Diluted)(2.61)(0.62)(1.62)(0.13)0.43
Weighted Avg Shares358.9M362M364.9M368M370.9M
Weighted Avg Shares (Diluted)358.9M362M364.9M368M375M

Bausch Health Companies Inc.

NYSE:BHC

Intrinsic Alpha fair value

Locked

Current Price

$8.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.